Best Telemedicine for Zepbound 2026
LillyDirect Vials from $349/mo
Zepbound is the FDA-approved branded form of tirzepatide for chronic weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist — the only dual-agonist on the market — and produces significantly greater weight loss than GLP-1-only agents in head-to-head trials. LillyDirect self-pay vials run $349–$550/month with savings cards; cash pay without coverage runs $1,000–$1,350/month.
Ro
Largest US telehealth platform
Why #1? Strong for branded-GLP-1 seekers; not the cheapest compounded option.
- Established platform with broad medical scope
- Branded GLP-1 emphasis (Wegovy/Zepbound)
- $149/mo membership on top of medication cost
- Less competitive on compounded pricing vs specialists
Calibrate
Coaching-led metabolic program
Why #2? Best for patients who treat GLP-1 as part of a larger metabolic program.
- Coaching-first model — strong clinical support
- Lab work included
- 3-month minimum commitment
- Higher all-in cost than self-serve programs
Ivim Health
360 wellness — branded + compounded + microdosing GLP-1
Why #3? Ivim Health has the deepest medication menu in our verified stack — branded, compounded, microdosing, and Wegovy Pill all available. Strong "Best for Variety" or "Best for Microdosing" candidate. Two-part pricing is the main friction point.
- Only verified provider with Microdosing GLP-1 Program
- Only verified provider with Compounded Liraglutide
- Only verified provider offering Wegovy Pill (oral semaglutide)
- Two-part pricing (medication + $74.99 program fee) less transparent than competitors
- 4-month minimum on hormone program
- Affiliate program not publicly listed
Found
Insurance-first weight-care platform
Why #4? Best for insured patients seeking branded GLP-1 coverage.
- Insurance-first model (lower out-of-pocket if covered)
- Both branded and compounded options
- Effectiveness depends on insurance coverage
- Membership fee separate from medication
Eden Health
Branded + compounded with intro pricing
Why #5? Eden Health is the broadest-catalog provider in our verified stack and has the strongest verified member count (127K+). The NAD+ ecosystem alone is a category they own. Strong "Best Value" or "Best for Wellness Stack" candidate.
- "Same Price at Every Dose" — no titration upcharge
- 127,000+ members (largest verified userbase)
- NAD+ in 5 different formats — owns the category
- 3-month plan pricing requires upfront commitment for lowest rate
- Monthly-without-commitment pricing higher ($229-249)
About Zepbound
Zepbound is the FDA-approved branded form of tirzepatide for chronic weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist — the only dual-agonist on the market — and produces significantly greater weight loss than GLP-1-only agents in head-to-head trials. LillyDirect self-pay vials run $349–$550/month with savings cards; cash pay without coverage runs $1,000–$1,350/month.
Mechanism: Dual GIP + GLP-1 receptor agonist — combines two incretin pathways for amplified appetite suppression and metabolic effect.
FDA Status: FDA-Approved
Dosing Schedule
| Week | Dose | Phase |
|---|---|---|
| Week 1 | 2.5 mg | Initiation |
| Week 5 | 5 mg | Titration |
| Week 9 | 7.5 mg | Titration |
| Week 13 | 10 mg | Titration |
| Week 17 | 12.5 mg | Titration |
| Week 21 | 15 mg | Maintenance |
Clinical Trial Results
Individual results vary. Clinical trial averages are not guarantees of personal outcome.
Common Side Effects
See your prescriber for the full list of potential side effects and contraindications.
Our Ranking Methodology
We weight five factors when ranking providers for each medication:
See our full methodology.
Not sure which provider fits you?
Take our 60-second quiz and get matched to your top 3 providers based on budget, medication preference, and insurance.